leisure time -WSS

leisure time

author：entertainment 2025-10-01 17:18:49 - browse：92236

A screen at the New York Stock Exchange last November. Michael M. Santiago/Getty Images

Pfizer spent more than four hours Thursday laying out its oncology program to investors. But the company also spent some time talking about the effects of the Inflation Reduction Act on its pipeline.

The drug giant, which is facing investor dissatisfaction after a year in which its stock dropped 44%, said it would be focusing on drugs that are based on proteins, not small molecule pills as it has traditionally developed. (Pfizer’s current best-seller in oncology, Ibrance for breast cancer, is a small molecule pill.) It said the mix of small molecule drugs in its cancer portfolio will drop from 94% last year to 35% in 2030.

That matters because small molecules are more vulnerable to generic competition and the Medicare price negotiation introduced by the IRA. Suneet Varma, the commercial president of Pfizer’s oncology unit, said “this planned shift to biologics is expected to support the accelerated growth in both the top and bottom line,” referring to the revenue and profit lines of a balance sheet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Covid hospitalizations on the rise, Humana says

WSS

Hospital price transparency does save money, advocate argues

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

Senate committee scrutinizes Medicare Advantage brokers

Beam Therapeutics to lay off 20% of its staff, re

Lawmakers consider Medicare pay reforms for doctors

FDA struggles to regulate food additives, sometimes for decades

entertainment

leisure time

knowledge

Psychedelics group wrestles with new pharma identity

STAT Summit: Biotech founders on deal

Tori Bowie and the unacceptable rates of Black maternal death

STAT Summit: Biotech founders on deal

Medical leaders decry Supreme Court decision on affirmative action

STAT Summit: How a Chicago ER doctor tackles gun violence

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

STAT Readout Newsletter: Today's biggest biotech updates

Walensky prepares to leave CDC — and Congress — behind

2023 STAT Wunderkinds: get to know the winners

entertainment

Humana sues Biden admin over Medicare Advantage audit rule

Why Novartis is changing the name of its research labs

Hospital price transparency does save money, advocate argues

STAT Summit: Michael J. Fox on progress in Parkinson's research

Impact of Dobbs ruling felt at reproductive medicine meeting

Humana sues Biden admin over Medicare Advantage audit rule

leisure time

leisure time

knowledge

Wikipedia